Michael Mitchell
Nessuna posizione attualmente
Profilo
Michael Mitchell worked as the Head of Investor Relations at The Medicines Co. from 2002 to 2013.
He holds an MBA from Rutgers State University of New Jersey and an undergraduate degree from Providence College.
Precedenti posizioni note di Michael Mitchell
| Società | Posizione | Fine |
|---|---|---|
| THE MEDICINES COMPANY | Contatto Relazioni con gli Investitori | - |
Formazione di Michael Mitchell
| Providence College | Undergraduate Degree |
| Rutgers State University of New Jersey | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
- Borsa valori
- Insiders
- Michael Mitchell
